Dalmia Bharat Sugar Q1 results: Net profit falls 10.8% to Rs 54.73 crore
Revenue from operations rose 15.2% to Rs 960 crore. However, total expenses rose 19.2% to Rs 901 crore. Illustration: Ajay
Continue reading
Tag: higher inventory
Broker’s call: Piramal Pharma (Outerperformer)
Target: ₹127 CMP: ₹104.40 Piramal Pharma reported healthy performance in Q2-FY24 which was above our estimate. Revenue stood at ₹1,911.40
Continue reading